Actieve functies van Nicholas Mark Barnes
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Directeur/Bestuurslid | 01-01-2004 | - |
| Algemeen Directeur | 01-01-2004 | - | |
| Oprichter | 01-01-2004 | - | |
| University of Birmingham | Corporate Officer/Principal | - | - |
| The International Union of Basic & Clinical Pharmacology | Corporate Officer/Principal | 04-04-2014 | - |
Loopbaan van Nicholas Mark Barnes
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Celentyx Ltd.
Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Health Technology |
| The International Union of Basic & Clinical Pharmacology |
